High expression of antiviral proteins in mucosa from individuals exhibiting resistance to human immunodeficiency virus

Several soluble factors have been reported to have the capacity of inhibiting HIV replication at different steps of the virus life cycle, without eliminating infected cells and through enhancement of specific cellular mechanisms.

Autores:
Gonzalez S.M.
Taborda N.A.
Feria M.G.
Arcia D.
Aguilar-Jiménez W.
Zapata Builes, Wildeman
Rugeles M.T.
Tipo de recurso:
Article of journal
Fecha de publicación:
2015
Institución:
Universidad Cooperativa de Colombia
Repositorio:
Repositorio UCC
Idioma:
OAI Identifier:
oai:repository.ucc.edu.co:20.500.12494/41899
Acceso en línea:
https://doi.org/10.17533/udea.redin.n87a05
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016646088&doi=10.6018%2feglobal.16.2.255821&partnerID=40&md5=201cd30734f88d71cc6069c89a2d4ca8
https://hdl.handle.net/20.500.12494/41899
Palabra clave:
apolipoprotein B messenger RNA editing enzyme catalytic polypeptide 3G
messenger RNA
protein ELAFIN
protein SAMHD1
protein SerpinA1
ribonuclease
RNase 7
tripartite motif protein 5
unclassified drug
virus protein
alpha 1 antitrypsin
antivirus agent
APOBEC3H protein
human
carrier protein
hydrolase
messenger RNA
monomeric guanine nucleotide binding protein
PI3 protein
human
ribonuclease
Ribonuclease 7
SAMHD1 protein
human
SERPINA1 protein
human
tiprelestat
TRIM5 protein
human
Article
CD4+ T lymphocyte
controlled study
cross-sectional study
genital mucosa
human
Human immunodeficiency virus
mouth mucosa
mucosa
nonhuman
peripheral blood mononuclear cell
protein expression
protein function
vagina mucosa
virus load
virus replication
virus resistance
adult
case control study
cohort analysis
disease course
female
female genital system
genetics
HIV Infections
HIV survivor
host pathogen interaction
immunology
lymphoid tissue
male
metabolis
Rights
closedAccess
License
http://purl.org/coar/access_right/c_14cb
Description
Summary:Several soluble factors have been reported to have the capacity of inhibiting HIV replication at different steps of the virus life cycle, without eliminating infected cells and through enhancement of specific cellular mechanisms.